Nationwide Fund Advisors - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 78 filers reported holding REPROS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$151,000
-16.6%
17,611
-3.1%
0.00%0.0%
Q4 2014$181,000
+1.7%
18,176
+1.1%
0.00%0.0%
Q3 2014$178,000
-42.4%
17,985
+0.8%
0.00%0.0%
Q2 2014$309,000
-1.6%
17,844
+0.9%
0.00%0.0%
Q1 2014$314,000
-3.1%
17,6810.0%0.00%0.0%
Q4 2013$324,000
-33.7%
17,681
-3.2%
0.00%
-50.0%
Q3 2013$489,000
+87.4%
18,264
+29.1%
0.00%
+100.0%
Q2 2013$261,00014,1520.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders